Ep29: Drug Interactions and Deprescribing

Pomegranate Health

Content provided by Managing Producer, Pomegranate. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Managing Producer, Pomegranate or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

6+ y ago

MP3•Episode home

Archived series ("Inactive feed" status)

When? This feed was archived on April 14, 2021 03:08 (3y ago). Last successful fetch was on October 07, 2020 06:07 (3+ y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Drug-drug interactions might be responsible for a million hospitalisations in Australia every year. They have become more frequent over the decades, as more medications reach the market. More than half of people over the age of 75 are on five or more prescriptions—a state referred to as polypharmacy. This episode examines some of the systems that have led to current rates of polypharmacy, and some strategies for deprescribing. We also discuss a review from the Internal Medicine Journal on the common drug interactions physicians should be most concerned about.
Guests: Professor Richard Day FRACP (St Vincent’s Hospital, UNSW), Professor Sarah Hilmer FRACP (Royal North Shore Hospital, University of Sydney).

Links to Professor Day’s article and related resources are provided at the RACP website.

63 episodes

#Australia #Managing Producer, Pomegranate #Medicine #Science